✦ LIBER ✦

Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica

✍ Scribed by A. Uddhammar; S. Rantapåå-Dahlqvist; T. K. Nilsson

Publisher: Springer
Year: 1992
Tongue: English
Weight: 443 KB
Volume: 11
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02207959

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue plasminogen activator, plasminoge

Tissue plasminogen activator, plasminogen activator inhibitor-1 and von willebrand factor in rheumatoid arthritis

✍ S. Wållberg-Jonsson; G. H. Dahlén; T. K. Nilsson; M. Rånby; S. Rantapää-Dahlqvis 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 598 KB

Plasma levels of tissue-type plasminogen

Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patient with Raynaud's phenomenon

✍ B. Marasini; M. Cugno; A. Agostoni 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

Correlation between von Willebrand facto

Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma

✍ Giuseppe Lippi; Massimo Franchini; Gian Luca Salvagno; Martina Montagnana; Giova 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 194 KB

Plasminogen- and colony-stimulating fact

Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis

✍ Champelovier, Pierre ;Boucard, Nathalie ;Levacher, Geraldine ;Simon, Annick ;Sei 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 312 KB

Transforming growth factor β1, urokinase

Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

✍ Fatima S. Pasini; M. Mitzi Brentani; Luiz P. Kowalski; Miriam H. H. Federico 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Background: A balance between urokinase-type plasminogen activator (upa) and its main inhibitor type-1 (pai-1) appears to be important for cancer invasive behavior. since upa/pai-1 system seems to be regulated by transforming growth factor beta1 (tgfbeta1) in different cell types, our aim was to

Circulating thrombomodulin as a novel en

Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von willebrand factor and tissue-type plasminogen activator

✍ Dr. Hoyu Takahashi; Seiki Ito; Masaharu Hanano; Ken Wada; Hiroe Niwano; Yoshinob 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB